Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger ...

A single multipurpose gene-editing tool can correct several genetic conditions by restoring proteins that have been truncated ...

A team of researchers at the Broad Institute, led by gene-editing pioneer David Liu, has developed a new genome-editing ...

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

Mitochondrial DNA (mtDNA) exhibits a degree of resistance to mutagenesis under genotoxic stress, and this study on the mitochondrial Transcription Factor A (TFAM) presents valuable data concerning the ...

This radical new method could preserve our entire knowledge base for thousands of years, in a storage medium the size of a ...

Moderna (MRNA) stock is in focus as the company completes U.S. mRNA production network, investing $140M in Massachusetts and ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the company's domestic production network.

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

A previously unknown type of DNA damage in the mitochondria, the tiny power plants inside our cells, could shed light on how ...